AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06729437 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham tDCS + Therapeutic eccentric exercise
Description: The current will be interrupted after 30 seconds.
Study NCT06727747 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Cervical traction
Description: Cervical traction procedure was performed using Saunders device. During the procedure, the patient lies in installed in a supine position with 20 degrees of cervical flexion and the physiotherapist gradually increases (5 minutes) the load to the defined kilograms which is maintained for 10 minutes then progressively decreases (5 minutes) the load to zero kilograms. The procedure is performed twice with a rest interval of 5 minutes.
Study NCT06727747 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cervical traction
Description: Cervical traction procedure was performed using Saunders device. During the procedure, the patient lies in installed in a supine position with 20 degrees of cervical flexion and the physiotherapist gradually increases (5 minutes) the load to the defined kilograms which is maintained for 10 minutes then progressively decreases (5 minutes) the load to zero kilograms. The procedure is performed twice with a rest interval of 5 minutes.
Study NCT06727747 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cervical traction
Description: Cervical traction procedure was performed using Saunders device. During the procedure, the patient lies in installed in a supine position with 20 degrees of cervical flexion and the physiotherapist gradually increases (5 minutes) the load to the defined kilograms which is maintained for 10 minutes then progressively decreases (5 minutes) the load to zero kilograms. The procedure is performed twice with a rest interval of 5 minutes.
Study NCT06727747 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Rehabilitation
Description: The rehabilitation program compiled cervical spine mobilization, stretching of neck muscles and isometric strengthening exercises. Passive stretching of neck muscles groups was carried-out in a seated position with 3 repetition of 30 seconds each. Isometric strengthening exercises of neck extensors were performed in a seated position, against the resistance of the physiotherapist hand for 3 repetitions of 10 seconds each
Study NCT06727747 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation
Description: The rehabilitation program compiled cervical spine mobilization, stretching of neck muscles and isometric strengthening exercises. Passive stretching of neck muscles groups was carried-out in a seated position with 3 repetition of 30 seconds each. Isometric strengthening exercises of neck extensors were performed in a seated position, against the resistance of the physiotherapist hand for 3 repetitions of 10 seconds each
Study NCT06727747 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation
Description: The rehabilitation program compiled cervical spine mobilization, stretching of neck muscles and isometric strengthening exercises. Passive stretching of neck muscles groups was carried-out in a seated position with 3 repetition of 30 seconds each. Isometric strengthening exercises of neck extensors were performed in a seated position, against the resistance of the physiotherapist hand for 3 repetitions of 10 seconds each
Study NCT06728098 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic
Description: The experimental phase of this study had last 84 days and each patient will make 4 visits (d1,d28,d56,d84).
Study NCT06728098 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: The experimental phase of this study had last 84 days and each patient will make 4 visits (d1,d28,d56,d84).
Study NCT06728098 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: The experimental phase of this study had last 84 days and each patient will make 4 visits (d1,d28,d56,d84).
Study NCT05958030 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo device consists of the same hardware as GyroGlove: aesthetically it looks the same, weight same and produces the same noise as GyroGlove. Participants will interact with Placebo on the day of baseline visit (i.e. Day 0).
Study NCT05958030 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GyroGlove
Description: GyroGlove is a patented wearable device containing high-performance, miniaturised, gyroscopes designed for individuals diagnosed with essential tremor. Participants will interact with GyroGlove on the day of baseline visit (i.e. Day 0), 2-week Home use and on the day of follow-up visit (i.e Day 14).
Study NCT05523505 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham intervention
Description: Use of the non-invasive brain stimulation device to simulate peripheral experience of stimulation without actually stimulating the brain.
Study NCT05523505 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RLN real non-invasive brain stimulation intervention
Description: Real non-invasive brain stimulation to the left angular gyrus and left temporal pole using transcranial alternating current stimulation (tACS).
Study NCT05523505 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CCN real non-invasive brain stimulation intervention
Description: Real non-invasive brain stimulation to the bilateral dorsolateral prefrontal cortex using transcranial alternating current stimulation (tACS).
Study NCT05523505 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RLN and CCN real non-invasive brain stimulation intervention
Description: Real non-invasive brain stimulation to the bilateral dorsolateral prefrontal cortex and left angular gyrus using transcranial alternating current stimulation (tACS).
Study NCT05404581 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: neuromodulation
Description: During the inpatient phase of the study, insular mapping will be performed with electrical stimulation to implanted SEEG electrodes in order to optimize the region for trial stimulation.~Subjects who respond favorably to trial stimulation in the hospital, will progress to the outpatient clinical trial phase where a DBS system will be implanted. All subjects will be blindly randomized to 3 months of stimulation and 3 months of sham stimulation.
Study NCT05404581 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: neuromodulation
Description: During the inpatient phase of the study, insular mapping will be performed with electrical stimulation to implanted SEEG electrodes in order to optimize the region for trial stimulation.~Subjects who respond favorably to trial stimulation in the hospital, will progress to the outpatient clinical trial phase where a DBS system will be implanted. All subjects will be blindly randomized to 3 months of stimulation and 3 months of sham stimulation.
Study NCT06203067 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Quarterly clinic visits with endocrinology provider.
Study NCT06203067 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Type 1 Together
Description: In Type 1 Together, families will work with other families who have experience using CGM (Peer Mentors) to overcome common barriers to CGM use. Families in the Type 1 Together program will also have access to CGM-specific educational materials, a digital journal to facilitate patient-provider communication around issues with CGM, and social determinant of health screening and intervention with a diabetes community health worker.
Study NCT05374213 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Intervention
Description: Mindfulness practices use a non-stigmatizing approach, combining secularized eastern meditative practices with western psychological advances to improve stress-management and self-care. Participants learn to generate less distress, engage more positively and fully in their lives and experiences, and respond more adaptively to challenges instead of reacting in automatic and unhelpful ways.
Study NCT05263206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: Injection solution subcutaneous
Study NCT05263206 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Injection solution SC
Study NCT05263206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fexofenadine (loratadine if not available)
Description: Tablet or capsule Oral
Study NCT05263206 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fexofenadine (loratadine if not available)
Description: Tablet or capsule Oral
Study NCT05263206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moisturizer
Description: Topical
Study NCT05263206 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Moisturizer
Description: Topical
Study NCT06122844 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social, Emotional, and Ethical Development (SEED) curriculum
Description: In response to fulfilling children's urgent psychosocial needs, the Bodhi Love Foundation (BLF) adapted the Kindness Curriculum for young children in Hong Kong by translating it from English to Chinese and adapting its length and content for implementation in the local kindergarten context. The adapted Kindness Curriculum, renamed as Social, Emotional, and Ethical Development curriculum (SEED), is a two-part program involving teacher training and delivery of SEED. The teacher training is consist of a 12-hour mindfulness course and a 1-day (6 hours) workshop to get familiarized with the understanding and practice of mindfulness, and the details of the SEED Curriculum. The SEED Curriculum involves 8 short sessions of basic techniques in mindfulness with 10 minutes each. In addition, it has 12 mindfulness-based lessons with specific themes for children in K2 and K3. Each lesson lasts for approximately 30-40 minutes.
Study NCT04420949 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sensory re-weighting
Description: During training, sensory re-weighting is driven by priming upregulation of somatosensory cues. Two rounds of training, each lasting 15 minutes and block-randomized in sets of 10 trials, are conducted per training visit. In each training trial, participants must determine the direction of gravity and then indicate if the rod being displayed is aligned with gravity or if it needs to rotate clockwise or counterclockwise for that to be so. Participants will be instructed to pay attention to what they feel from their feet, legs, and gut during training and to use that pressure, stretch, movement, and muscle tension feedback to help them sense gravity. Immediate auditory and non-orienting, visual feedback is provided after each trial. A staircase method is used to adapt the level of difficulty based on response accuracy. After two consecutive correct responses, the difficulty increases. After each incorrect response, the difficulty decreases. This process is repeated in each round.
Study NCT04023773 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Liver Machine Perfusion (MP) device
Description: Donor livers will have ex vivo continuous perfusion on the institutional-developed Liver MP device. The temperature of liver grafts will be controlled during perfusion.
Study NCT05457075 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Immune checkpoint measure
Description: The measurement of soluble immune checkpoints of stage II-III rectal cancer before neoadjuvant treatment
Study NCT05709340 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: proprioceptive neuromuscular facilitation exercises
Description: PNF exercises will be done for Masseter, Temporalis, Lateral pterygoid and medial pterygoid muscles. Each contraction will be held for 10 seconds, and each stretch (relaxation phase) will be allowed to continue as long as the muscle tension continued to give away.
Study NCT05709340 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional physical therapy treatment
Description: * Ultrasound: Continuous ultrasound at 1MHZ to temporomandibular joint at 1.0-1.25 W/CM2 for 5 min over each affected TMJ and masseter area, with the mouth in a slightly open position.~* Forward head posture correction exercises including: chin tuck exercise, Strengthening shoulder retractors, stretching of sternocleidomastoid muscle, and Stretching of pectoralis muscle.
Study NCT06145477 — intervention group
Intervention type: BEHAVIORAL
Intervention: Chicago Parent Program - individualized for families (CPPi)
Description: CPPi is a 8-12 session individual- based parenting skills program
Study NCT06079619 — intervention group
Intervention type: OTHER
Intervention: Analysis of photos of pigmented tumours by the three groups
Description: Analysis of photos of pigmented tumours by the three groups with different techniques for each group to compare them.
Study NCT05651152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JZP441
Description: Nighttime oral dose
Study NCT05651152 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Nighttime oral dose
Study NCT06191822 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Nutrition
Description: Interact with mobile app and work toward personalized nutrition goals
Study NCT06191822 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Fitness
Description: Interact with mobile app and work toward personalized fitness goals
Study NCT06191822 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sleep
Description: Interact with mobile app and work toward personalized sleep goals
Study NCT05444582 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Levonorgestrel 52 MG Intrauterine System
Description: Eligible participants must be 16-35 years old, meet clinic eligibility for IUD placement, and having a LNG 52 mg IUD placed for either:~Emergency Contraception (had unprotected intercourse in the last 5 days) OR Same-day start - >7 days since the onset of last menstrual period and have no report of unprotected intercourse in the last 5 days.
Study NCT05894395 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MMR booster vaccination (as M-M-R-VaxPro)
Description: a single dose of MMR-containing vaccine (as M-M-R-VaxPro), in adults having previously received 2 lifetime doses of MMR-containing vaccine
Study NCT05190874 — intervention group
Intervention type: DEVICE
Intervention: Grappler Interference Screw System
Description: Foot and/or ankle procedure involving soft tissue attachment to bone using the Grappler® Interference Screw System
Study NCT06253377 — intervention group
Intervention type: DEVICE
Intervention: Adsorption membrane filter Oxiris™
Description: Continuous Renal Replacement Therapy with the adsorption membrane filter Oxiris™
Study NCT05537168 — intervention group
Intervention type: PROCEDURE
Intervention: Pediatric cardiac surgery under cardiopulmonary bypass
Description: All patients with pediatric cardiac surgery under cardiopulmonary bypass between 2008 and 2018 operated at our institution
Study NCT05776043 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Empagliflozin 10 MG
Description: once daily for 6 or 9 months
Study NCT05776043 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin 10 MG
Description: once daily for 6 or 9 months
Study NCT05776043 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: once daily for 3 months
Study NCT04128761 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scarcity Narrative
Description: Participants are presented with a hypothetical scarcity narrative and asked to listen and consider the scenario.
Study NCT04128761 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Neutral Narrative
Description: Participants are presented with a hypothetical neutral narrative and asked to listen and consider the scenario.
Study NCT03856515 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement
Description: Received NRT (Electronic Cigarette - With Nicotine)
Study NCT03856515 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03856515 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electronic Cigarette
Description: Electronic Cigarette - with Nicotine
Study NCT03856515 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electronic Cigarette
Description: Electronic Cigarette -without Nicotine
Study NCT06378996 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 14-day rhythm monitoring
Description: Eligible patients will be monitored during 14 days using the Byteflies patch ambulatory rhythm monitor.
Study NCT06609603 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HTGT compound
Description: oral administration of HTGT compound once daily
Study NCT06609603 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral administration of placebo once daily
Study NCT04837651 — intervention group
Intervention type: DEVICE
Intervention: Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test
Description: Subjects will receive an Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test within 4 weeks of receiving their first COVID-19 injection. Within 3-4 weeks of receipt of their final COVID-19 vaccine dose, subjects will receive another Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test.
Study NCT04837651 — intervention group
Intervention type: DEVICE
Intervention: T-Detect COVID T-cell blood test
Description: A select number of subjects will also receive a qualitative SARS-CoV-2 t-cell immunity test, the T-Detect COVID test, within 3-4 weeks of receipt of their final COVID-19 vaccine dose.
Study NCT04907565 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sampling
Description: 4 tubes of 7 mL of blood will be collected
Study NCT04907565 — intervention group
Intervention type: BIOLOGICAL
Intervention: white adipose tissue sampling
Description: At the beginning of the surgery, samples of white adipose tissue from the surgical wound will be collected.
Study NCT05101018 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romosozumab
Description: Romosozumab (Amgen Inc., Thousand Oaks, CA) 210mg SQ administered each month
Study NCT05101018 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Denosumab
Description: Denosumab (Amgen Inc., Thousand Oaks, CA) 60 mg SQ administered every six months
Study NCT05101018 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab
Description: Denosumab (Amgen Inc., Thousand Oaks, CA) 60 mg SQ administered every six months
Study NCT05330598 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Connected Catheter
Description: The Connected Catheter System is a replaceable wireless urinary prosthesis that is indicated for bladder emptying in male patients who have impaired bladder emptying due to chronic Urinary Retention. The Connected Catheter resides fully internally in the male lower urinary tract (urethra and bladder neck) and remains in place for up to 7 days before removal.
Study NCT06364787 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: γδ T cells
Description: Cells will be extracted from a healthy donor by apheresis, followed by ex-vivo expansion and activation. The ex-vivo expanded γδ T cells from donors will be adoptively transfused.
Study NCT06364787 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Targeted drugs
Description: Multi-target kinase inhibitors can act on VEGFR-1,VEGFR-2,VEGFR-3,FGFR1,PDGFR,cKit,Ret and other targets.
Study NCT06364787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Targeted drugs
Description: Multi-target kinase inhibitors can act on VEGFR-1,VEGFR-2,VEGFR-3,FGFR1,PDGFR,cKit,Ret and other targets.
Study NCT06364787 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PD-1 monoclonal antibody
Description: Humanized programmed death receptor (PD-1) monoclonal antibody that binds to PD- and prevents binding of PD-1 with programed death ligands 1 (PD-L1) and PD-L2. It can function to activate cytotoxic T lymphocytes and inhibit tumor growth.
Study NCT06364787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1 monoclonal antibody
Description: Humanized programmed death receptor (PD-1) monoclonal antibody that binds to PD- and prevents binding of PD-1 with programed death ligands 1 (PD-L1) and PD-L2. It can function to activate cytotoxic T lymphocytes and inhibit tumor growth.
Study NCT06475430 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: fecal microbiota transplantation
Description: During the treatment, a colonoscopic colonic catheter will be placed via the anus, with the experimental group receiving FMT solution matched to the patient's microbiota for intra-intestinal administration.
Study NCT06475430 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Formulated probiotic supplements
Description: During the treatment, a colonoscopic colonic catheter will be placed via the anus, with the control group receiving a standardized probiotic formula.
Study NCT06040593 — intervention group
Intervention type: OTHER
Intervention: No drug
Description: This is a non-interventional study and no study drug will be provided.
Study NCT05612503 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Traditional physical therapy program
Description: resistance-based diaphragm strengthening exercises, breathing exercises to increase costal or chest breathing, and breathing exercises to relax the breathing muscles.
Study NCT05612503 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional physical therapy program
Description: resistance-based diaphragm strengthening exercises, breathing exercises to increase costal or chest breathing, and breathing exercises to relax the breathing muscles.
Study NCT05612503 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality-based exercises
Description: Virtual reality exercise using Nintendo Wii systems. As game interfaces, the Nintendo Wii systems employ haptic sensor-based controllers and a balance board.